1. Home
  2. PGEN vs VERI Comparison

PGEN vs VERI Comparison

Compare PGEN & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • VERI
  • Stock Information
  • Founded
  • PGEN 1998
  • VERI 2014
  • Country
  • PGEN United States
  • VERI United States
  • Employees
  • PGEN N/A
  • VERI N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • VERI EDP Services
  • Sector
  • PGEN Health Care
  • VERI Technology
  • Exchange
  • PGEN Nasdaq
  • VERI Nasdaq
  • Market Cap
  • PGEN 493.0M
  • VERI 438.8M
  • IPO Year
  • PGEN N/A
  • VERI 2017
  • Fundamental
  • Price
  • PGEN $4.78
  • VERI $4.34
  • Analyst Decision
  • PGEN Buy
  • VERI Strong Buy
  • Analyst Count
  • PGEN 5
  • VERI 5
  • Target Price
  • PGEN $7.67
  • VERI $10.00
  • AVG Volume (30 Days)
  • PGEN 4.5M
  • VERI 7.1M
  • Earning Date
  • PGEN 11-13-2025
  • VERI 11-06-2025
  • Dividend Yield
  • PGEN N/A
  • VERI N/A
  • EPS Growth
  • PGEN N/A
  • VERI N/A
  • EPS
  • PGEN N/A
  • VERI N/A
  • Revenue
  • PGEN $6,309,000.00
  • VERI $98,027,000.00
  • Revenue This Year
  • PGEN $249.10
  • VERI $19.12
  • Revenue Next Year
  • PGEN $710.03
  • VERI $18.83
  • P/E Ratio
  • PGEN N/A
  • VERI N/A
  • Revenue Growth
  • PGEN 59.20
  • VERI 0.74
  • 52 Week Low
  • PGEN $0.65
  • VERI $1.22
  • 52 Week High
  • PGEN $5.23
  • VERI $9.42
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 68.44
  • VERI 38.10
  • Support Level
  • PGEN $3.74
  • VERI $5.15
  • Resistance Level
  • PGEN $4.04
  • VERI $5.47
  • Average True Range (ATR)
  • PGEN 0.33
  • VERI 0.59
  • MACD
  • PGEN 0.02
  • VERI -0.31
  • Stochastic Oscillator
  • PGEN 75.11
  • VERI 10.53

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Share on Social Networks: